Speaker illustration

Doctor Rene Rettl

Medical University of Vienna, Vienna (Austria)

Member of:

Heart Failure Association

DPD quantification correlates with ECV and disease severity in transthyretin cardiac amyloidosis

Event: Heart Failure 2024

Topic: Hypertrophic Cardiomyopathy

Session: Cardiomyopathies: present and future

Thumbnail

Novel SPECT/CT biomarker in transthyretin cardiac amyloidosis: correlation with myocardial amyloid load and cardiac structure and function

Event: ESC Congress 2023

Topic: Imaging of Myocardial Disease

Session: New imaging insights into cardiomyopathies

Thumbnail

Monitoring patisiran and inotersen treatment with quantitative SPECT/CT in hereditary transthyretin amyloid cardiomyopathy

Event: ESC Congress 2023

Topic: Infiltrative Myocardial Disease

Session: Cardiac amyloidosis: prognosis and treatment monitoring

Thumbnail

Two-dimensional speckle-tracking echocardiography in tafamidis-treated patients with transthyretin amyloid cardiomyopathy: a glimmer of hope for viable therapy monitoring?

Event: ESC Congress 2022

Topic: Infiltrative Myocardial Disease

Session: Cardiac amyloidosis

Thumbnail

Cardiac imaging in tafamidis-treatment patients with transthyretin amyloid cardiomyopathy

Event: ESC Congress 2021 - The Digital Experience

Topic: Infiltrative Myocardial Disease

Session: Myocardial and pericardial disease e-posters

Thumbnail

Quantification of myocardial amyloid deposition in tafamidis-treated patients with transthyretin amyloid cardiomyopathy

Event: ESC Congress 2021 - The Digital Experience

Topic: Infiltrative Myocardial Disease

Session: Myocardial and pericardial disease e-posters

Thumbnail

Effects of tafamidis on quantification of myocardial amyloid deposits in patients with transthyretin amyloid cardiomyopathy

Event: Heart Failure 2021

Topic: Hypertrophic Cardiomyopathy

Session: Myocardial Disease

Thumbnail

Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy

Event: Heart Failure 2021

Topic: Hypertrophic Cardiomyopathy

Session: Young Investigator Award: clinical research

Thumbnail

Effects of tafamidis on exercise capacity, cardiac function and myocardial amyloid deposition in patients with transthyretin amyloid cardiomyopathy

Event: ESC Congress 2020

Topic: Treatment

Session: Chronic Heart Failure ePosters

Thumbnail

Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy

Event: ESC Congress 2019

Topic: Treatment

Session: Inflammatory, infiltrative and cardiomyopathy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb